Summary
Genetic polymorphism of human factor I (C3b inactivator) has been described using polyacrylamide gel isoelectric focusing electrophoresis of neuraminidase-treated EDTA plasma samples followed by electrophoretic blotting technique. In 435 individuals three different common patterns were observed, and these were controlled by two common alleles at a single locus. The results of typing family material confirmed autosomal codominant Mendelian inheritance. Two common alleles were designated FI*B and FI*A, and gene frequencies were estimated to be 0.8931 and 0.1069 for FI*B and FI*A, respectively. The distribution of phenotypes fitted the Hardy-Weinberg equilibrium. Linkage studies failed to show close linkage between factor I and the major histocompatibility complex.
Similar content being viewed by others
References
Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH (1971) Deficiency of C3 inactivator in man. J Immunol 107:19–27
Allen FH Jr (1974) Linkage of HLA and GBG Vox Sang 27:382–384
Alper CA, Propp RP (1968) Genetic polymorphism of the third component of human complement (C-prime-3). J Clin Invest 47:2181–2192
Alper CA, Abramson N, Johnston RB Jr, Jandl JH, Rosen FS (1970) Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3) N Engl J Med 282:349–354
Alper CA, Boenisch T, Watson L (1972a) Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med 135:68–79
Alper CA, Rosen FS, Lachmann PJ (1972b) Inactivator of the third component of complement as an inhibitor in the properdin pathway. Proc Natl Acad Sci USA 69:2910–2913
Alper CA, Raum D, Karp S, Awdeh ZL, Yunis EJ (1983) Serum complement “supergenes” of the major histocompatibility complex in man (complotypes) Vox Sang 45:62–67
Awdeh ZL, Alper CA (1980) Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 77:3576–3580
Azen EA, Smithies O (1968) Genetic polymorphism of C-prime-3 (beta-1C-globulin) in human serum. Science 162:905–907
Cooper NR (1975) Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serum. J Exp Med 141:890–903
Fujita T, Gigli I, Nussenzweig V (1978) Human C4-binding protein: II. Role in proteolysis of C4b by C3b-inactivator. J Exp Med 148:1044–1051
Hobart MJ, Joysey V, Lachmann PJ (1978) Inherited structural variation and linkage relationships of C7. J Immunogenet 5:157–163
Lachmann PJ, Müller-Eberhard HJ (1968) The demonstration in human serum of “conglutinogen-activating factor” and its effect on the third component of complement. J Immunol 100:691–698
Martin A, Lachmann PJ, Halbwachs L, Hobart MJ (1976) Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry 13:317–324
Nakamura S, Ooue O, Abe K (1984a) Genetic polymorphism of the seventh component of complement in a Japanese population. Hum Genet 66:279–281
Nakamura S, Ooue O, Akiyama K, Abe K (1984b) Genetic polymorphism of complement C6 and haplotype analysis between C6 and C7 in a Japanese population. Hum Genet 68:138–141
Pangburn MK, Schreiber RD, Müller-Eberhard HJ (1977) Human complement C3b inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution. J Exp Med 146:257–270
Raum D, Marcus D, Alper CA (1980) Genetic polymorphism of human plasminogen. Am J Hum Genet 32:681–689
Raum DD, Awdeh ZL, Glass AD, Yunis E, Alper CA (1981) The location of C2, C4, and BF relative to HLA-B and HLA-D. Immunogenetics 12:473–483
Rodriguez de Cordoba S, Rubinstein P (1984) Genetic polymorphism of human factor H (β1H) J Immunol 132:1906–1908
Rodriguez de Cordoba S, Ferreira A, Nussenzweig V, Rubinstein P (1983) Genetic polymorphism of human C4-binding protein. J Immunol 131:1565–1569
Ruddy S, Austen FK (1971) C3b inactivator of man: II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. J Immunol 107:742–750
The Nomenclature Committee of the IUIS (1981) Nomenclature of the alternative activating pathway of complement. J Immunol 127:1261–1262
Thompson RA, Lachmann PJ (1977) A second case of human C3b inhibitor (KAF) deficiency. Clin Exp Immunol 27:23–29
Whitehouse DB, Putt W (1983) Immunological detection of the sixth complement component (C6) following flat bed polyacrylamide gel isoelectric focusing and electrophoretic transfer to nitrocellulose filters. Ann Hum Genet 47:1–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakamura, S., Abe, K. Genetic polymorphism of human factor I (C3b inactivator). Hum Genet 71, 45–48 (1985). https://doi.org/10.1007/BF00295667
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00295667